glp-1 obesity drug news today The Multi-Sector Impacts of GLP-1RA Drugs As GLP-1 drugs continue to

Studies have found that GLP-1R is widely distributed on pancreatic and other tissues and has multiple biological effects, such as reducing neuroinflammation, promoting nerve growth, improving heart function, suppressing appetite, delaying gastric emptying, regulating blood lipid metabolism and reducing fat deposition

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2)

All these changes, particularly in the first few weeks of treatment or in the early days of dose adjustment, can leave the body feeling drained while the body adapts

Tirzepatide: The Dual-Action Upgrade Tirzepatide is newer and works differently

Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series

Persistent or worsening fatigue beyond several months warrants medical review to exclude anaemia, thyroid dysfunction, or other contributing conditions